Guillaume Charpentier

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Roux En Y Gastric Bypass

Systemic Sclerosis

Top Venues

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Meulebrouck, Victoria Scherrer, Raphaël Boutry, Bénédicte Toussaint, Emmanuel Vaillant, Aurélie Dechaume, Hélène Loiselle, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Morgane Baron, Martine Vaxillaire, Mehdi Derhourhi, Mathilde Boissel, Phillippe Froguel, Amélie Bonnefond
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia (2023)
Stewart B Harris, Martin J Abrahamson, Antonio Ceriello, Guillaume Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard Ian Gregory Holt, Nóra Hosszúfalusi, Guy E H M Rutten, Tina Vilsbøll
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes. Drugs 80 (2) (2020)
Nathalie Jeandidier, Lucy Chaillous, Sylvia Franc, Pierre Yves Benhamou, Pauline Schaepelynck, Hélène Hanaire, Bogdan Catargi, Anne Farret, Pierre Fontaine, Bruno Guerci, Yves Reznik, Alfred Penfornis, Sophie Borot, Pierre Serusclat, Yacine Kherbachi, Geneviève D'Orsay, Bruno Detournay, Pierre Simon, Guillaume Charpentier
DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR research protocols 7 (4) (2018)